Results 181 to 190 of about 114,739 (248)
In tumor cells, ENH prompts the interaction between YAP and KPNA2. This interaction enables YAP to translocate into the nucleus, where it enhances the transcription of CCL5. Consequently, this up‐regulation of CCL5 drives the infiltration of tumor‐associated macrophages (TAMs) and their polarization toward the M2 phenotype, ultimately facilitating ...
Yueli Shi+14 more
wiley +1 more source
Cellular reprogramming as a tool to model human aging in a dish. [PDF]
Pitrez PR+5 more
europepmc +1 more source
A hollow nanomotor (PM‐HMSN/Arg) propelled by ultrasound‐triggered nitric oxide (NO) was developed. The nanomotor employs a “tethering‐relaxing‐drilling” mechanism to overcome biological barriers, enabling multimodal theranostics of cancer with deep penetration and extended lifetime.
Xue Xu+7 more
wiley +1 more source
Orchestrating an immune response to cancer with cellular reprogramming. [PDF]
Zimmermannova O+2 more
europepmc +1 more source
Comparative Biology of Vertebrate Retinal Regeneration: Restoration of Vision through Cellular Reprogramming. [PDF]
Todd L, Reh TA.
europepmc +1 more source
This study elucidates a novel SlJAZ8‐SlWRKY57‐SlAVT6A/SlAVT6B module that effectively channels metabolic flux from primary to secondary metabolism, impacting plant growth, development, and resistance. Two novel vacuolar amino acid exporters, SlAVT6A and SlAVT6B, fine‐tunes trichomes, terpenes, and gibberellins, bolstering spider mite resistance.
Yingchen Hao+11 more
wiley +1 more source
Cellular reprogramming in vivo initiated by SOX4 pioneer factor activity. [PDF]
Katsuda T+13 more
europepmc +1 more source
Role of epigenetics in cellular reprogramming; from iPSCs to disease modeling and cell therapy. [PDF]
Li Y, Darabi R.
europepmc +1 more source
DeepNEU: cellular reprogramming comes of age – a machine learning platform with application to rare diseases research [PDF]
Wayne R. Danter
openalex +1 more source
Small RNA Toxin‐Assisted Evolution of GC‐Preferred ErCas12a for Enhanced Genome Targeting Range
ErCas12a is engineered to target GC‐rich PAMs using a small RNA toxin‐aided positive screening system. The resulting variant, enErCas12a, exhibits an expanded PAM profile and facilitates efficient gene editing in both bacterial and mammalian cells, while preserving high targeting specificity for both canonical and non‐canonical PAM targets.
Zehua Chen+8 more
wiley +1 more source